Xianbiao Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xianbiao Xie has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Changye Zou
The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
1 shared publication - Hanxiao Yin
The First Affiliated Hospital of Sun Yat‐sen University Guangzhou China
1 shared publication - Jingnan Shen
Department of Musculoskeletal Oncology, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
1 shared publication Junqiang Yin
Department of Orthopaedic Oncology, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China
1 shared publication- Junqiang Yin
Department of Musculoskeletal Oncology, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
1 shared publication - Li-Li Wen
Department of Laboratory Medicine, En Chu Kong Hospital, Taipei Taiwan
1 shared publication
Latest Publications
- Open Access
- 27 November 2025
- Published by Wiley in Orthopaedic Surgery
- Vol. 18 (1) , 53-65
The Application of Orthopedic Surgical Robot‐Assisted Technology in Various Clinical Scenarios Involving Bone Tumors
Objectives: Over the past three decades, orthopedic surgical robots have experienced rapid advancements. This study, a case series, aimed to investigate the effectiveness, limitations, and technical improvements associated with the application of robots in the surgical treatment of bone tumors. Methods: From November 2021 to October 2023, 54 patients with bone tumors who provided consent for robot‐assisted surgery were included. Patients were divided into three groups based on specific objectives: robot‐assisted path planning, pedicle screw insertion, and intraoperative real‐time navigation‐assisted tumor resection. Perioperative conditions were meticulously recorded for all patients, including intraoperative blood loss, operation duration, postoperative complications, and tumor diameter. Results: Nineteen patients underwent robot‐assisted tissue biopsies, and pathological examinations confirmed a positive rate of 84.21%. Among the 21 patients undergoing robot‐assisted pedicle screw placement, surgical planning was executed with high accuracy. Twenty patients undergoing robot‐assisted lesion excision achieved precise resection of the tumor‐affected bone segments as planned preoperatively, and no secondary osteotomies were required. No perioperative complications related to the use of robots were observed in the 54 patients. To address the limitation of orthopedic robots in differentiating soft tissues, we integrated ultrasound technology and the da Vinci robot. Additionally, patient‐specific cutting guides were utilized to compensate for the prolonged operation time associated with planar planning using orthopedic robots. Conclusions: Robot‐assisted technology facilitates the precise planning of the surgical path and determination of the osteotomy plane. The integration of orthopedic robots with intraoperative ultrasound or Da Vinci robots can potentially further ensure the safety of bone tumor surgery while maintaining its accuracy, thereby minimizing the risk of complications associated with surgical procedures. Furthermore, this technology combined with patient‐specific cutting guides may be conducive to reducing operation time.
- 27 November 2025
- Published by Wiley in Orthopaedic Surgery
- Vol. 18 (1) , 53-65
Open AccessThe Application of Orthopedic Surgical Robot‐Assisted Technology in Various Clinical Scenarios Involving Bone Tumors
Objectives: Over the past three decades, orthopedic surgical robots have experienced rapid advancements. This study, a case series, aimed to investigate the effectiveness, limitations, and technical improvements associated with the application of robots in the surgical treatment of bone tumors. Methods: From November 2021 to October 2023, 54 patients with bone tumors who provided consent for robot‐assisted surgery were included. Patients were divided into three groups based on specific objectives: robot‐assisted path planning, pedicle screw insertion, and intraoperative real‐time navigation‐assisted tumor resection. Perioperative conditions were meticulously recorded for all patients, including intraoperative blood loss, operation duration, postoperative complications, and tumor diameter. Results: Nineteen patients underwent robot‐assisted tissue biopsies, and pathological examinations confirmed a positive rate of 84.21%. Among the 21 patients undergoing robot‐assisted pedicle screw placement, surgical planning was executed with high accuracy. Twenty patients undergoing robot‐assisted lesion excision achieved precise resection of the tumor‐affected bone segments as planned preoperatively, and no secondary osteotomies were required. No perioperative complications related to the use of robots were observed in the 54 patients. To address the limitation of orthopedic robots in differentiating soft tissues, we integrated ultrasound technology and the da Vinci robot. Additionally, patient‐specific cutting guides were utilized to compensate for the prolonged operation time associated with planar planning using orthopedic robots. Conclusions: Robot‐assisted technology facilitates the precise planning of the surgical path and determination of the osteotomy plane. The integration of orthopedic robots with intraoperative ultrasound or Da Vinci robots can potentially further ensure the safety of bone tumor surgery while maintaining its accuracy, thereby minimizing the risk of complications associated with surgical procedures. Furthermore, this technology combined with patient‐specific cutting guides may be conducive to reducing operation time.
- 1 June 2020
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 313, 128015
Manipulations of DNA four-way junction architecture and DNA modified Fe3O4@Au nanomaterials for the detection of miRNA
- 1 June 2020
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 313, 128015
Manipulations of DNA four-way junction architecture and DNA modified Fe3O4@Au nanomaterials for the detection of miRNA
- Open Access
- 1 January 2014
- Published by Wiley in Mediators of Inflammation
- Vol. 2014, 1-9
Anti-Inflammatory and Antinociceptive Activities of Bufalin in Rodents
The aims of this study were to evaluate the anti-inflammatory and analgesic effects of bufalin, a major component of “Chan-su.” We used a carrageenan-induced paw edema model to assess the anti-inflammatory activity of this compound, and Western blot analysis detected NF-κB signaling during this effect. The antinociceptive activities were evaluated by acetic acid-induced writhing, formalin, and hot-plate tests; open-field test investigated effects on the central nervous system. Our data showed that bufalin (0.3 and 0.6 mg/kg, i.p.) potently decreased carrageenan-induced paw edema. Bufalin down regulated the expression levels of nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interleukin-1β(IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α(TNF-α) during these treatments. Further studies demonstrated that bufalin significantly inhibited the activation of NF-κB signaling. Bufalin also reduced acetic acid-induced writhing and the licking time in the formalin test and increased hot-plate reaction latencies. Naloxone pretreatment (2 mg/kg, i.p.) in the early phases of the formalin test and hot-plate test significantly attenuated the bufalin-induced antinociception effects, which suggests the involvement of the opioid system. A reduction in locomotion was not observed in the open-field test after bufalin administration. Taken together, bufalin treatment resulted in in vivo anti-inflammatory and analgesic effects, and bufalin may be a novel, potential drug for the treatment of inflammatory diseases.
- 1 January 2014
- Published by Wiley in Mediators of Inflammation
- Vol. 2014, 1-9
Open AccessAnti-Inflammatory and Antinociceptive Activities of Bufalin in Rodents
The aims of this study were to evaluate the anti-inflammatory and analgesic effects of bufalin, a major component of “Chan-su.” We used a carrageenan-induced paw edema model to assess the anti-inflammatory activity of this compound, and Western blot analysis detected NF-κB signaling during this effect. The antinociceptive activities were evaluated by acetic acid-induced writhing, formalin, and hot-plate tests; open-field test investigated effects on the central nervous system. Our data showed that bufalin (0.3 and 0.6 mg/kg, i.p.) potently decreased carrageenan-induced paw edema. Bufalin down regulated the expression levels of nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interleukin-1β(IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α(TNF-α) during these treatments. Further studies demonstrated that bufalin significantly inhibited the activation of NF-κB signaling. Bufalin also reduced acetic acid-induced writhing and the licking time in the formalin test and increased hot-plate reaction latencies. Naloxone pretreatment (2 mg/kg, i.p.) in the early phases of the formalin test and hot-plate test significantly attenuated the bufalin-induced antinociception effects, which suggests the involvement of the opioid system. A reduction in locomotion was not observed in the open-field test after bufalin administration. Taken together, bufalin treatment resulted in in vivo anti-inflammatory and analgesic effects, and bufalin may be a novel, potential drug for the treatment of inflammatory diseases.